Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies

被引:0
|
作者
Siegel, Dana R. [1 ]
Van Harn, Meredith [2 ]
Taguchi, Meari [4 ]
Bansal, Poonam [3 ,4 ]
Cerghet, Mirela [1 ,4 ]
Memon, Anza B. [1 ,4 ]
机构
[1] Wayne State Univ, Sch Med, 540 East Canfield, Detroit, MI 48201 USA
[2] Henry Ford Hosp, Dept Publ Hlth Sci, 2799 West Grand Blvd, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Ophthalmol, 2799 West Grand Blvd, Detroit, MI 48202 USA
[4] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA
关键词
Optic neuritis; Multiple sclerosis; Aquaporin-4; Myelin oligodendrocyte glycoprotein; PROFILE;
D O I
10.1016/j.clineuro.2022.107381
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Optic neuritis (ON) is an immune-mediated optic neuropathy associated with multiple immunemediated neurological conditions. Our aim was to characterize the clinical and diagnostic features of first or initial episodes of ON associated with multiple sclerosis (MS)-associated (typical) and antibody-related (atypical) ON. Methods: Retrospective, single institution, medical record review. We analyzed demographic, clinical, laboratory, and radiographic findings of 139 patients who presented with first episodes of MS-associated ON (MS-ON), aquaporin 4 antibody-associated ON (AQP4-ON), and myelin oligodendrocyte glycoprotein antibody-associated ON (MOG-ON) between January 2015 and October 2019 without preceding diagnosis. Simple hypothesis testing assessed differences between groups were performed. Results: Of 139 patients (109 [79 %] women; 29 [21 %] men; mean age 47 [SD, 14] years), 106 had MS-ON, 25 had AQP4-ON, and 8 had MOG-ON. Patients with MOG-ON had the highest recurrence rate (88 %) relative to MS-ON (28 %) and AQP4-ON (56 %) patients (P <.001). Patients with AQP4-ON had the highest mean visual functional system scores (4.3 [SD, 1.8]) relative to MS-ON (2.0 [SD, 1.9]) and MOG-ON patients (2.8 [SD, 2.0]) (P <.001). Conclusion: Patients presenting with initial episodes of ON exhibit a range radiographic and laboratory feature depending on the underlying associated disease. Understanding the variable characteristics of typical (MSassociated)
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis
    Reder, AT
    Oger, JJ
    NEUROLOGY, 2004, 62 (11) : 1922 - 1923
  • [2] More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies
    Lerch, Magdalena
    Schanda, Kathrin
    Lafon, Eliott
    Wuerzner, Reinhard
    Mariotto, Sara
    Dinoto, Alessandro
    Wendel, Eva Maria
    Lechner, Christian
    Hegen, Harald
    Rostasy, Kevin
    Berger, Thomas
    Wilflingseder, Doris
    Hoeftberger, Romana
    Reindl, Markus
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (01):
  • [3] Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
    Akaishi, Tetsuya
    Fujimori, Juichi
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Takai, Yoshiki
    Nishiyama, Shuhei
    Kaneko, Kimihiko
    Ogawa, Ryo
    Abe, Michiaki
    Ishii, Tadashi
    Aoki, Masashi
    Fujihara, Kazuo
    Nakashima, Ichiro
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 349
  • [4] Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Paediatric Patients with Optic Neuritis
    Tegetmeyer, Helmut
    Merkenschlager, Andreas
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (10) : 1243 - 1249
  • [5] Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis
    Rostasy, Kevin
    Mader, Simone
    Schanda, Kathrin
    Huppke, Peter
    Gaertner, Jutta
    Kraus, Verena
    Karenfort, Michael
    Tibussek, Daniel
    Blaschek, Astrid
    Bajer-Kornek, Barbara
    Leitz, Steffen
    Schimmel, Mareike
    Di Pauli, Franziska
    Berger, Thomas
    Reindl, Markus
    ARCHIVES OF NEUROLOGY, 2012, 69 (06) : 752 - 756
  • [6] Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein
    Ducloyer, Jean-Baptiste
    Michel, Laure
    Wiertlewski, Sandrine
    Lebranchu, Pierre
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (02) : 257 - 261
  • [7] Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures
    Gutrnan, Josef Maxwell
    Kupersmith, Mark
    Galetta, Steven
    Kister, Ilya
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 387 : 170 - 173
  • [8] Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis
    Tsuburaya, Rie S.
    Miki, Naoki
    Tanaka, Keiko
    Kageyama, Takashi
    Irahara, Kaori
    Mukaida, Souichi
    Shiraishi, Kazuhiro
    Tanaka, Masami
    BRAIN & DEVELOPMENT, 2015, 37 (01): : 145 - 148
  • [9] Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study
    Manish Salunkhe
    Pranjal Gupta
    Rajesh K. Singh
    Kamalesh Tayade
    Vinay Goel
    Ayush Agarwal
    Animesh Das
    Arunmozhimaran Elavarasi
    Awadh K. Pandit
    Deepti Vibha
    Ajay Garg
    Leve Joseph Devarajan Sebastian
    Rohit Bhatia
    Manjari Tripathi
    Shailesh Gaikwad
    MVPadma Srivastava
    Neurological Sciences, 2023, 44 : 2475 - 2489
  • [10] Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study
    Salunkhe, Manish
    Gupta, Pranjal
    Singh, Rajesh K.
    Tayade, Kamalesh
    Goel, Vinay
    Agarwal, Ayush
    Das, Animesh
    Elavarasi, Arunmozhimaran
    Pandit, Awadh K.
    Vibha, Deepti
    Garg, Ajay
    Sebastian, Leve Joseph Devarajan
    Bhatia, Rohit
    Tripathi, Manjari
    Gaikwad, Shailesh
    Srivastava, MVPadma
    NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2475 - 2489